Merdad Parsey Gilead Sciences, Inc. (GILD) insider trading activity

Merdad Parsey is Chief Medical Officer of GILEAD SCIENCES, INC.. Currently has a direct ownership of 99,599 shares of GILD, which is worth approximately $9.01 Million. The most recent transaction as insider was on Nov 06, 2024, when has been sold 25,590 shares (Common Stock) at a price of $91.5 per share, resulting in proceeds of $2,341,485. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.6K

3.34% 3M change

42.02% 12M change

Total Value Held $9.01 Million

Merdad Parsey Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 06 2024	SELL Open market or private sale	$2,341,485 $91.5 p/Share	25,590 Reduced 20.44%	99,599 Common Stock
Nov 06 2024	BUY Exercise of conversion of derivative security	$1,448,000 $57.92 p/Share	25,000 Added 16.65%	125,189 Common Stock
Oct 01 2024	SELL Open market or private sale	$167,660 $83.83 p/Share	2,000 Reduced 1.96%	100,189 Common Stock
Sep 12 2024	SELL Open market or private sale	$1,795,287 $84.5 p/Share	21,246 Reduced 17.21%	102,189 Common Stock
Sep 12 2024	BUY Exercise of conversion of derivative security	$1,448,000 $57.92 p/Share	25,000 Added 16.84%	123,435 Common Stock
Sep 10 2024	SELL Payment of exercise price or tax liability	$143,823 $81.44 p/Share	1,766 Reduced 1.76%	98,435 Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	-	3,821 Added 3.67%	100,201 Common Stock
Jul 01 2024	SELL Open market or private sale	$137,260 $68.63 p/Share	2,000 Reduced 2.03%	96,380 Common Stock
Jun 10 2024	SELL Payment of exercise price or tax liability	$113,796 $65.25 p/Share	1,744 Reduced 1.74%	98,380 Common Stock
Jun 10 2024	BUY Exercise of conversion of derivative security	-	3,820 Added 3.68%	100,124 Common Stock
Apr 01 2024	SELL Open market or private sale	$145,920 $72.96 p/Share	2,000 Reduced 2.03%	96,304 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	$360,801 $75.12 p/Share	4,803 Reduced 4.66%	98,304 Common Stock
Mar 10 2024	BUY Exercise of conversion of derivative security	-	10,401 Added 9.16%	103,107 Common Stock
Feb 29 2024	SELL Open market or private sale	$598,650 $72.74 p/Share	8,230 Reduced 8.15%	92,706 Common Stock
Feb 28 2024	SELL Open market or private sale	$146,360 $73.18 p/Share	2,000 Reduced 1.94%	100,936 Common Stock
Jan 31 2024	SELL Payment of exercise price or tax liability	$1,855,466 $78.26 p/Share	23,709 Reduced 18.77%	102,616 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	76,853 Added 37.83%	126,325 Common Stock
Dec 10 2023	SELL Payment of exercise price or tax liability	$100,276 $79.02 p/Share	1,269 Reduced 1.74%	71,640 Common Stock
Dec 10 2023	BUY Exercise of conversion of derivative security	-	2,779 Added 3.67%	72,909 Common Stock
Sep 12 2023	SELL Open market or private sale	$115,561 $76.99 p/Share	1,501 Reduced 2.1%	70,130 Common Stock
Sep 10 2023	SELL Payment of exercise price or tax liability	$97,128 $76.0 p/Share	1,278 Reduced 1.75%	71,631 Common Stock
Sep 10 2023	BUY Exercise of conversion of derivative security	-	2,779 Added 3.67%	72,909 Common Stock
Jun 13 2023	SELL Open market or private sale	$114,196 $76.9 p/Share	1,485 Reduced 4.81%	29,402 Common Stock
Jun 10 2023	SELL Payment of exercise price or tax liability	$101,087 $78.12 p/Share	1,294 Reduced 4.02%	30,887 Common Stock
Jun 10 2023	BUY Exercise of conversion of derivative security	-	2,779 Added 7.95%	32,181 Common Stock

Also insider at

SGMT

Sagimet Biosciences Inc.

Director

Merdad Parsey

Chief Medical Officer

Foster City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account